109 related articles for article (PubMed ID: 15059503)
1. [Evidence-based medicine and drug selection of osleoporosis prevention after menopause].
Xu L
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):265-6. PubMed ID: 15059503
[No Abstract] [Full Text] [Related]
2. [Raloxifene].
Hofbauer LC; Heufelder AE
Dtsch Med Wochenschr; 1999 Jan; 124(1-2):19-20. PubMed ID: 9951454
[No Abstract] [Full Text] [Related]
3. Raloxifene: a new class of anti-estrogens for the prevention of osteoporosis.
Kupecz D
Nurse Pract; 1998 Sep; 23(9):91-3. PubMed ID: 9778672
[No Abstract] [Full Text] [Related]
4. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
Urano T
Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770
[TBL] [Abstract][Full Text] [Related]
5. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
Ohta H
Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
[TBL] [Abstract][Full Text] [Related]
6. Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk.
Lippman ME; Cummings SR; Disch DP; Mershon JL; Dowsett SA; Cauley JA; Martino S
Clin Cancer Res; 2006 Sep; 12(17):5242-7. PubMed ID: 16951244
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene for prevention of osteoporotic fractures.
Diehr S; Mijal S; Nashelsky J
Am Fam Physician; 2005 Jul; 72(1):132-4. PubMed ID: 16035693
[No Abstract] [Full Text] [Related]
8. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
9. [Additional effect of SERM: central nervous system].
Honjo H
Clin Calcium; 2004 Oct; 14(10):69-72. PubMed ID: 15577134
[TBL] [Abstract][Full Text] [Related]
10. Drug information needs clarification.
Grossman LD
Can Fam Physician; 2001 Jan; 47():28-30. PubMed ID: 11212427
[No Abstract] [Full Text] [Related]
11. Not all SERMs are created equal.
Goldstein SR
Menopause; 2006; 13(3):325-7. PubMed ID: 16735926
[No Abstract] [Full Text] [Related]
12. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
Ohta H
Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
[TBL] [Abstract][Full Text] [Related]
13. [Current trends in prevention and therapy of postmenopausal osteoporosis].
Rossi G
Recenti Prog Med; 1998 Jun; 89(6):288. PubMed ID: 9658894
[No Abstract] [Full Text] [Related]
14. Raloxifene: bone and cardiovascular effects.
Francucci CM; Romagni P; Boscaro M
J Endocrinol Invest; 2005; 28(10 Suppl):85-9. PubMed ID: 16550730
[TBL] [Abstract][Full Text] [Related]
15. Drugs for prevention and treatment of postmenopausal osteoporosis.
Treat Guidel Med Lett; 2002 Nov; 1(3):13-8. PubMed ID: 15529101
[No Abstract] [Full Text] [Related]
16. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
Rosa J; Vanuga P; Payer J; Svobodník A
Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
[TBL] [Abstract][Full Text] [Related]
17. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
18. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.
Schaefers M; Muysers C; Alexandersen P; Christiansen C
Menopause; 2009; 16(3):559-65. PubMed ID: 19423999
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
Kozakiewicz K; Wycisk A
Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene and its role in breast cancer prevention.
Eng-Wong J; Zujewski JA
Expert Rev Anticancer Ther; 2004 Aug; 4(4):523-32. PubMed ID: 15270657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
